Bendeka is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Bendamustine Hydrochloride.
Product ID | 63459-348_01ec2935-0653-4173-8e90-b3e3dbb135a6 |
NDC | 63459-348 |
Product Type | Human Prescription Drug |
Proprietary Name | Bendeka |
Generic Name | Bendamustine Hydrochloride |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2015-12-08 |
Marketing Category | NDA / NDA |
Application Number | NDA208194 |
Labeler Name | Teva Pharmaceuticals USA, Inc. |
Substance Name | BENDAMUSTINE HYDROCHLORIDE |
Active Ingredient Strength | 25 mg/mL |
Pharm Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2015-12-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208194 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-12-08 |
Ingredient | Strength |
---|---|
BENDAMUSTINE HYDROCHLORIDE | 25 mg/mL |
SPL SET ID: | ace9a43b-f9bd-4896-abfe-0ef4fec67ddf |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
63459-348 | Bendeka | bendamustine hydrochloride |
42367-521 | BELRAPZO | bendamustine hydrochloride |
10019-079 | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride |
16729-250 | bendamustine hydrochloride | bendamustine hydrochloride |
16729-251 | bendamustine hydrochloride | bendamustine hydrochloride |
42367-520 | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride |
63459-390 | TREANDA | Bendamustine Hydrochloride |
63459-391 | TREANDA | Bendamustine Hydrochloride |
71225-120 | VIVIMUSTA | BENDAMUSTINE HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BENDEKA 86611898 4938294 Live/Registered |
Cephalon, Inc. 2015-04-28 |